Chinese materia medica mainly prevents and treats diminished ovarian reserve by regulating PI3K/Akt, PI3K/Akt/mTOR, PI3K/Akt/FoxO3, PTEN/PI3K/Akt, TGF-β1/Smads, Nrf2/HO-1, AMPK and other signaling pathways. It also involves Hippo, Wnt / β-catenin, Notch and other signaling pathways, which can improve the ovarian environment, promote ovarian function repair, inhibit ovarian granulosa cell apoptosis, promote oocyte growth, regulate hormone levels, and play anti-inflammatory, anti-oxidation and anti-fibrosis roles.